A U.S. District Court in Washington slammed the door on Masimo Corp.’s latest push against Apple Inc.’s smartwatches. On April 24, 2026, the court dismissed with prejudice the medical-device maker’s complaint targeting the U.S. International Trade Commission and Customs and Border Protection. All parties agreed to the move. Gone—for now—is Masimo’s shot at reinstating an import ban on Apple Watches equipped with blood-oxygen tech. AppleInsider broke the news first, detailing how the filing followed the ITC’s own rejection of Masimo’s plea just a week earlier. The saga stretches back to 2020. Masimo accused Apple of poaching talent and swiping pulse-oximetry secrets for the Apple Watch’s blood-oxygen sensor. By 2021, Masimo lodged an ITC complaint over Series 6 models. Victory came in late 2023: the ITC barred U.S. imports of infringing watches, yanking Series 9 and Ultra 2 off shelves right before Christmas. Apple dodged disaster with a swift software tweak, disabling the feature stateside. U.S.…